Stephen R. Jaspers
57Patents
11h-index
39Co-inventors
78Inventor score
Filing activity: Dec 28, 1995 → Apr 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5959075A | Testis-specific insulin homolog polypeptides | Human Necessities | 70 | Expired |
| US7910703B2 | Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use | Emerging Cross-Sectional Technologies | 38 | Active |
| US7790163B2 | Antibodies that bind both IL-17A and IL-17F and methods of using the same | Emerging Cross-Sectional Technologies | 38 | Active |
| US6114307A | Methods for stimulating pancreatic islet cell regeneration | Human Necessities | 28 | Expired |
| US8333968B2 | Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19 | Emerging Cross-Sectional Technologies | 26 | Active |
| US6897286B2 | Zsig33-like peptides | Human Necessities | 18 | Expired |
| US6416988B1 | Beta-1,3-galactosyltransferase homologs | Chemistry; Metallurgy | 15 | Expired |
| US8496936B2 | Antagonists of IL-17A, IL-17F, and IL-23P19 | Emerging Cross-Sectional Technologies | 15 | Active |
| US7910540B2 | Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation | Chemistry; Metallurgy | 15 | Active |
| US6709659B1 | Antibodies that bind testis-specific insulin homolog polypeptides | Chemistry; Metallurgy | 14 | Expired |
| US7445919B2 | Zsig33-like peptides and polynucleotides | Human Necessities | 12 | Expired |
| US8609099B2 | Antibodies that bind both IL-17A and IL-17F | Emerging Cross-Sectional Technologies | 11 | Active |
| US7655447B2 | ZSIG33-like polynucleotides | Human Necessities | 11 | Active |
| US8557544B2 | Polynucleotides encoding antibodies that bind both IL-17A and IL-17F | Emerging Cross-Sectional Technologies | 11 | Active |
| US6627729B1 | TML peptides | Human Necessities | 10 | Expired |
| US8268773B2 | Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist | Chemistry; Metallurgy | 10 | Active |
| US6420521B1 | Short gastrointestinal peptides | Human Necessities | 9 | Expired |
| US8871467B2 | Polynucleotides encoding antibodies that bind both IL-17A and IL-17F | Emerging Cross-Sectional Technologies | 7 | Active |
| US6838438B2 | Motilin Homologs | Human Necessities | 6 | Expired |
| US7923539B2 | IL-21 antagonists | Emerging Cross-Sectional Technologies | 5 | Active |
| US8992922B2 | Antagonists of IL-17A, IL-17F, and IL-23P19 | Emerging Cross-Sectional Technologies | 5 | Active |
| US6013503A | Human prohormone convertase 4 | Chemistry; Metallurgy | 5 | Expired |
| US7704950B2 | Methods of using soluble heterodimeric cytokine receptor | Chemistry; Metallurgy | 4 | Active |
| US6939690B2 | Polynucleotides encoding motilin homologs | Human Necessities | 4 | Expired |
| US9388241B2 | Anti-human IL-21 antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.